Adrenergic Receptor Agonist Intermediate Synthesis With Safer Reagents
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing synthesis process for adrenergic receptor agonist intermediates is costly due to expensive raw materials, hazardous reagents, and environmentally unfriendly byproducts, posing safety risks and complicating commercial-scale production.
Innovation Solution
A method using readily available starting materials and mild reaction conditions to synthesize adrenergic receptor agonist intermediates, avoiding toxic reagents and generating safe byproducts, suitable for commercial-scale production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the existing synthesis process uses expensive raw materials and hazardous reagents, then the target compound can be synthesized, but production costs increase and safety risks arise
Solution Approach 1:
The patent changes the chemical parameters of the synthesis process by using different reagents (e.g., replacing chlorosulfonyl isocyanate with safer alternatives) and adjusting reaction conditions (temperature, time, catalysts) to maintain synthesis effectiveness while eliminating hazardous substances and reducing costs
Solution Approach 2:
The patent employs readily available, inexpensive starting materials and reagents that can be easily disposed of or replaced, avoiding the need for expensive raw materials and hazardous chemicals, thereby reducing production costs and safety concerns
2Productivity
If high reaction temperature is used to promote reaction rate, then product formation increases, but polymerization occurs and tar-like polymers are generated
Solution Approach 1:
The patent optimizes reaction parameters including temperature, pressure, concentration, and catalyst selection to achieve high reaction rates without promoting polymerization. By carefully controlling these parameters, the process produces desired products efficiently while minimizing harmful byproducts like tar-like polymers
Solution Approach 2:
The patent introduces catalysts or additives that act as intermediaries to facilitate the desired reaction at lower temperatures, preventing direct high-temperature reactions that cause polymerization. These intermediaries enable efficient product formation while suppressing unwanted side reactions
3Manufacturing precision
If column chromatography is used for purification, then product purity is achieved, but the process becomes unsuitable for commercial-scale production
Solution Approach 1:
The patent modifies purification parameters by replacing column chromatography with scalable techniques such as crystallization, filtration, or extraction methods that can be performed at commercial scales. These alternative methods maintain product purity while being suitable for large-scale production
Solution Approach 2:
The patent extracts and removes impurities through scalable separation techniques that can be implemented in commercial settings, avoiding the need for labor-intensive column chromatography. The process efficiently separates desired products from byproducts using methods that scale well with production volume
4Ease of manufacture
If the reaction generates cyclopentadiene as byproduct, then the reaction pathway is established, but environmental friendliness and operator safety are compromised
Solution Approach 1:
The patent converts harmful reaction pathways into beneficial ones by redesigning the synthesis route to eliminate cyclopentadiene generation. Alternative reaction pathways are introduced that produce environmentally friendly byproducts or no harmful substances, maintaining reaction efficiency while improving environmental and safety profiles
Solution Approach 2:
The patent introduces alternative reagents or catalysts that act as intermediaries to facilitate the desired reaction without generating harmful byproducts. These intermediaries enable the reaction to proceed through safer pathways, eliminating cyclopentadiene formation while maintaining productive reaction outcomes
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method reduces production costs, enhances yield, and ensures safe, environmentally friendly commercial-scale production of adrenergic receptor agonist intermediates.
Implementation Method 1
contacting a first compound of formula E1 or E2 with a second compound of formula F0 to yield a third compound of formula C
Data Source
AI summary
A method for preparing an intermediate of an adrenergic receptor agonist. The method comprises the following steps: cyclizing the compound of formula E1 or the compound of formula E2 and the compound of formula F0 to obtain the compound of formula C, where R1 is methyl, ethyl, isopropyl, propyl, tert-butyl, or butyl; R3 is H, Cl, F or Br; and L1 and L2 are each individually a leaving group. The method uses easily available raw materials, avoids the use of toxic and harmful reagents, is mild in terms of reaction conditions, is simple to operate, achieves a substantial improvement in yield and reduction in cost, and is more favorable for commercial production.